OVERVIEW
Our Pioneering Technologies
Omeza combines compelling clinical validation with a scalable commercial model addressing a large and underserved market. Its use of sustainably sourced, marine-derived biological compounds positions the company at the forefront of a new generation of regenerative wound care solutions.
Omeza’s lead product, OCM™, is an FDA-cleared drug-device wound matrix derived from marine lipids and cold-water fish peptides. Applied in various settings, it reduces inflammation, disrupts bacterial biofilm, and supports tissue regeneration, offering a highly effective and cost-efficient alternative to traditional skin grafts.
OUR PURPOSE
Vision & Mission Statement
Our Mission
To make advanced wound care accessible, sustainable and cost-effective
Our Goal
To become the new standard of care for skin ulcers and hard-to-heal wounds
Our Approach
Simple, safe, sustainable and clinically-proven
UN SUSTAINABLE DEVELOPMENT GOALS
OUR MISSION
Restoring Skin Integrity
Wound Management & Prevention (WMP) Journal selected Omeza for a ‘Top Innovation in Wound Care 2022’ Award for the Omeza products bundle. At the core of this award-winning system is the Omeza® Complete Matrix Rx, engineered to decrease inflammation, increase proliferation, support remodeling, and reduce biofilm impact at any site of care.
View More
SUSTAINABILITY
Our Natural Ingredients Deliver On Our Commitment To A Sustainable Future Of Wound Care
Omeza’s proprietary formulations include omega-3-, -6, and -9 oils and nutrients in a rapidly penetrating delivery system.
By prioritizing marine-derived biotechnology, waste upcycling and sustainable sourcing, those ingredients represent the pinnacle of the circular Blue Economy by utilizing discarded fish components. This directly aligns with the US National Strategy for a Sustainable Ocean Economy and the broader US Blue Economy initiatives.
Hydrolyzed Fish Collagen
Sourced from North Atlantic white fish, it acts as a structural scaffold that allows new skin and tissue to regenerate.
Cod Liver Oil
Provides a rich source of vitamins (A, C, D, E) and serves as an anhydrous skin protectant to maintain a moist healing environment and support natural barrier repair.
Omega Fatty Acids
Includes naturally occurring Omega 3, 6, and 9 to help decrease inflammation, manage bacterial contamination (like biofilms), and support tissue remodeling.
OUR HISTORY
The History Of Omeza Holdings, Inc.
Research began into the unique wound healing properties of marine life at the world-renowned Mote Marine Laboratory in Sarasota, FL, USA.
2013
Omeza LLC was formed to explore different therapeutic applications in wound care and dermatology, utilizing advanced chemical engineering to develop its core formulations.
2014
Omeza’s lead product, OCM™, was FDA cleared in September 2021 as a 510(k) bioactive device, with instructions for use in hard-to-heal chronic wounds and acute wounds.
2021
Omeza LLC converted to Omeza Holdings Inc., a registered corporation, in January 2022. This corporate structure allows for further development globally of multiple therapeutic applications of OMEZA’s proprietary technology.
2022
By early 2025, Omeza had published 7 peer-reviewed publications on OCM™, studying 200 patients with a variety of very serious hard-to-heal wounds.
2025
Omeza concluded its first Series A financing in April.
2026
Connect with Our Experts
Direct your inquiry to the appropriate Omeza division, clinical, scientific, or corporate, and let's advance the future of wound care together.
Contact Us